News Search Results
Feb 12, 2026, 19:00 ET Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed in the pivotal Phase 3 clinical study (HeriCare-Breast01).
More news about: Innovent Biologics
Feb 12, 2026, 10:32 ET Veterinary Imaging Market worth $3.332 billion by 2031 | MarketsandMarkets™
Veterinary Ophthalmology Equipment Market - Global Forecast to 2031
More news about: MarketsandMarkets
Feb 12, 2026, 10:01 ET Veterinary Ophthalmology Equipment Market worth $0.83 billion by 2031 | MarketsandMarkets™
400 market data Tables and 65 Figures spread through 450 Pages and in-depth TOC on "Veterinary Ophthalmology Equipment Market - Global Forecast to 2031"Veterinary Ophthalmology Equipment Market Size & Forecast:Market Size Available for Years: 2025–20312026
More news about: MarketsandMarkets
Feb 12, 2026, 08:32 ET rater8 Announces Winners of the 2025 Practice Excellence Awards
performers across rater8's 10 most-represented specialties: cardiology, ENT, family medicine, gastroenterology, hospital, multi-specialty, OBGYN, ophthalmology, orthopedics, and urology. Winners in each specialty were selected based on the highest overall ratings from rater8 patient reviews collected in
More news about: rater8
Feb 11, 2026, 07:13 ET HelpMeSee Launches New Simulation-based Training Center in Ghana to Advance Cataract Surgery Education in West Africa
region."The Ghana training center serves as:A national training hub to improve the competency of Ghana's ophthalmology workforce.A regional center of excellence for West Africa, promoting cross-border training collaborations.A model for
More news about: HelpMeSee
Feb 11, 2026, 07:13 ET HelpMeSee Launches New Simulation-based Training Center in Ghana to Advance Cataract Surgery Education in West Africa
region."The Ghana training center serves as:A national training hub to improve the competency of Ghana's ophthalmology workforce.A regional center of excellence for West Africa, promoting cross-border training collaborations.A model for
More news about: HelpMeSee
Feb 10, 2026, 11:58 ET Regenerative Medicine Market to Reach $531.7 billion, Globally, by 2033 at 32.4% CAGR: Allied Market Research
Material, Genetically Engineered Material and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the regenerative medicine market
More news about: Allied Market Research
Feb 10, 2026, 08:00 ET AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases
the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology/ophthalmology/ skin health businesses, bringing economies of scale in specialty fields.About Insilico MedicineInsilico Medicine is a pioneering
More news about: Insilico Medicine
Feb 10, 2026, 07:00 ET CooperVision Launches MiSight® 1 day in Japan; Becomes First Myopia Control Contact Lens in Leading Vision Care Market
CooperVision. "The launch of MiSight® 1 day in Japan represents an enormous step forward in that mission. Partnering with Japan's revered ophthalmology community, we are helping young patients see clearly today while protecting their vision for the future."Myopia affects nearly one in three
More news about: CooperVision, Inc.
Feb 10, 2026, 07:00 ET InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.Forward-Looking
More news about: InMode Ltd.
Feb 05, 2026, 11:49 ET Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Critical Care
Feb 05, 2026, 11:43 ET HelpMeSee Unveils Next-Generation MSICS Training System at SAFO to Scale Global Blindness Solutions
Manual Small Incision Cataract Surgery (MSICS) Training System at the French-Speaking African Ophthalmology Society (SAFO) conference.
More news about: HelpMeSee
Feb 05, 2026, 11:36 ET Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Critical Care
Feb 05, 2026, 10:57 ET HelpMeSee Unveils Next-Generation MSICS Training System at SAFO to Scale Global Blindness Solutions
Manual Small Incision Cataract Surgery (MSICS) Training System at the French-Speaking African Ophthalmology Society (SAFO) conference.
More news about: HelpMeSee
Feb 05, 2026, 08:00 ET Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
models, supporting broad indication potential expanding into autoimmune and inflammatory diseases, metabolic diseases, cardiovascular diseases and ophthalmology diseases. Moreover, ISM5059 is predicted to be efficacious at a low dose in humans, providing a high safety margin for future validation.Specifically,
More news about: Insilico Medicine
Feb 05, 2026, 08:00 ET Sun Pharma Introduces SUNday, Highlighting the Everyday Realities of Skin Cancer Care
company in the U.S. as well as Global Emerging Markets. Sun's high growth Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for about 20% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharma
Feb 04, 2026, 10:00 ET Dr. Nathaniel Nataneli Joins OCLI Vision as Cornea Specialist
Medicine and JAMA Ophthalmology, and has authored multiple book chapters on topics ranging from dry eye disease to corneal endotheliitis.Dr. Nataneli is a Diplomate of the American Board of Ophthalmology and an active member of the American Academy of Ophthalmology and the American Society
More news about: OCLI Vision
Feb 04, 2026, 09:06 ET Sectra continues to have the world's happiest customers--wins Best in KLAS Awards in North America, Europe, Middle East/Africa, and Oceania
is an integral part of Sectra's enterprise imaging solution, also comprising VNA and imaging modules for pathology, cardiology, orthopedics, ophthalmology, and genomics in one single system.To read the US and global reports, visit:
More news about: Sectra
Feb 04, 2026, 09:00 ET SECTRA CONTINUES TO HAVE THE WORLD'S HAPPIEST CUSTOMERS--WINS BEST IN KLAS AWARDS IN NORTH AMERICA, EUROPE, MIDDLE EAST/AFRICA, AND OCEANIA
module is an integral part of Sectra's enterprise imaging solution, also comprising VNA and imaging modules for pathology, cardiology, orthopedics, ophthalmology, and genomics in one single system.To read the US and global reports, visit:
More news about: Sectra
Feb 03, 2026, 13:02 ET Beverly Hills Oculoplastic Surgeon Dr. Kami Parsa Launches Mendora, a new skincare ecosystem offering a science-backed approach to skin wellness
Clinical Professor at USC's Department of Ophthalmology and Department of Plastic Surgery, Dr. Parsa has published extensively in medical literature and lectures internationally on advances in periocular rejuvenation. He is a member of the American Academy of Ophthalmology and fellowship trained by the American
More news about: Mendora
Feb 03, 2026, 08:00 ET InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.Investor
More news about: InMode Ltd.
Feb 03, 2026, 08:00 ET ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
drug modalities.Roee Farber, MD, CEO of ZipBio, said: "MeiraGTx's expertise in development of best-in-class genetic medicines in ophthalmology makes them the ideal partner to bring our next generation AI-designed Geographic Atrophy therapies to patients with a significant unmet need. This
More news about: ZipBio
Feb 02, 2026, 18:00 ET ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization
from Shanghai Jing'an District Shibei Hospital.The ZEISS ARTEVO 850 is a 3D-enabled digital microscope designed for multiple specialties in ophthalmology, setting the pace in digital visualization. It combines the proven benefits of a digital ophthalmic microscope with customizable 3D digital visualization,
More news about: Carl Zeiss Meditec AG
Feb 02, 2026, 18:00 ET ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization
from Shanghai Jing'an District Shibei Hospital.The ZEISS ARTEVO 850 is a 3D-enabled digital microscope designed for multiple specialties in ophthalmology, setting the pace in digital visualization. It combines the proven benefits of a digital ophthalmic microscope with customizable 3D digital visualization,
More news about: Carl Zeiss Meditec AG
Feb 02, 2026, 11:07 ET Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions